199 related articles for article (PubMed ID: 19475364)
1. The economic costs of diabetes: a population-based study in Tehran, Iran.
Esteghamati A; Khalilzadeh O; Anvari M; Meysamie A; Abbasi M; Forouzanfar M; Alaeddini F
Diabetologia; 2009 Aug; 52(8):1520-7. PubMed ID: 19475364
[TBL] [Abstract][Full Text] [Related]
2. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
[TBL] [Abstract][Full Text] [Related]
3. The impact of diabetes mellitus on healthcare costs in Italy.
Giorda CB; Manicardi V; Diago Cabezudo J
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates.
Al-Maskari F; El-Sadig M; Nagelkerke N
BMC Public Health; 2010 Nov; 10():679. PubMed ID: 21059202
[TBL] [Abstract][Full Text] [Related]
5. [Cost of diabetes mellitus in Spain].
González P; Faure E; Del Castillo A;
Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
[No Abstract] [Full Text] [Related]
6. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
7. Costs of diabetes and its complications in Poland.
Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
[TBL] [Abstract][Full Text] [Related]
8. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
9. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.
Mata-Cases M; Casajuana M; Franch-Nadal J; Casellas A; Castell C; Vinagre I; Mauricio D; Bolíbar B
Eur J Health Econ; 2016 Nov; 17(8):1001-1010. PubMed ID: 26542160
[TBL] [Abstract][Full Text] [Related]
11. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
Marcellusi A; Viti R; Mecozzi A; Mennini FS
Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
[TBL] [Abstract][Full Text] [Related]
12. The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory.
Pagano E; De Rosa M; Rossi E; Cinconze E; Marchesini G; Miccoli R; Vaccaro O; Bonora E; Bruno G
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):944-50. PubMed ID: 27289165
[TBL] [Abstract][Full Text] [Related]
13. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
Salman RA; AlSayyad AS; Ludwig C
BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
[TBL] [Abstract][Full Text] [Related]
15. The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study.
Köster I; von Ferber L; Ihle P; Schubert I; Hauner H
Diabetologia; 2006 Jul; 49(7):1498-504. PubMed ID: 16752168
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of diabetic foot ulcer: a case of Iran.
Hashempour R; MirHashemi S; Mollajafari F; Damiri S; ArabAhmadi A; Raei B
BMC Health Serv Res; 2024 Mar; 24(1):363. PubMed ID: 38515182
[TBL] [Abstract][Full Text] [Related]
17. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
[TBL] [Abstract][Full Text] [Related]
18. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
19. Cost of diabetes care in out-patient clinics of Karachi, Pakistan.
Khowaja LA; Khuwaja AK; Cosgrove P
BMC Health Serv Res; 2007 Nov; 7():189. PubMed ID: 18028552
[TBL] [Abstract][Full Text] [Related]
20. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
Köster I; Hauner H; von Ferber L
Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
